British Columbia Investment Management’s Pediatrix Medical MD Stock Holding History

British Columbia Investment Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-51,969	Closed	-$2.24M	–	699
2017 Q3	$2.24M	Sell	51,969 -19,776	-28%	-$940K	0.02%	617
2017 Q2	$4.33M	Sell	71,745 -80,925	-53%	-$4.8M	0.03%	505
2017 Q1	$10.6M	Buy	152,670 +78,806	+107%	+$5.47M	0.08%	300
2016 Q4	$4.92M	Buy	73,864 +615	+0.8%	+$40K	0.04%	457
2016 Q3	$4.85M	Buy	73,249 +6,203	+9%	+$424K	0.05%	438
2016 Q2	$4.86M	Buy	67,046 +45,023	+204%	+$3.1M	0.04%	455
2016 Q1	$1.42M	Sell	22,023 -13,799	-39%	-$915K	0.01%	629
2015 Q4	$2.57M	Buy	+35,822	New	+$2.65M	0.02%	580

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

British Columbia Investment Management's MD Position: Q4 2017 in Review

British Columbia Investment Management sold out of Pediatrix Medical (MD) in Q4 2017, closing a stake of 51,969 shares — an estimated $2.24M sold.

British Columbia Investment Management first reported a position in MD in Q4 2015 and held it in 8 quarters. The position peaked at $10.6M in Q1 2017. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

British Columbia Investment Management reported no remaining Pediatrix Medical position as of Q4 2017 after selling out during the quarter.
British Columbia Investment Management sold 51,969 Pediatrix Medical shares in Q4 2017, an estimated $2.24M.
British Columbia Investment Management first reported a position in Pediatrix Medical in Q4 2015 and held it in 8 quarters.
British Columbia Investment Management's Pediatrix Medical position peaked at $10.6M in Q1 2017.
330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on British Columbia Investment Management's 13F filing for Q4 2017, filed 20 Feb 2018.